Skip to main content

H.R. 1478

Referred to Committee

Affordable Insulin Act of 2019

Introduced 2/28/2019•116th Congress•House

Latest Action

Referred to the Subcommittee on Health.

3/1/2019 • House

Summary

Affordable Insulin Act of 2019

This bill addresses the importation of insulin from Canada and other foreign countries.

The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain insulin from Canada. The FDA may also permit the importation of insulin from certain other countries under specified circumstances.

The bill also establishes a process for certifying licensed foreign pharmacies and foreign wholesale distributors.

Introduced in House • 2/28/2019

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Administrative law and regulatory proceduresCanadaCongressional oversightDepartment of Health and Human ServicesDigestive and metabolic diseasesDrug safety, medical device, and laboratory regulationGovernment information and archivesGovernment studies and investigationsPrescription drugsTrade restrictionsUser charges and fees

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (2)

Party Breakdown

1
Democrats
1
Republicans
0
Independents

Sponsor

RL
Rep. Welch, Peter [D-VT-At Large]

Democrat • VT

Sponsored 2/28/2019

Cosponsors (1)

R[
Rep. Rooney, Francis [R-FL-19]

R-FL-19

Joined 2/28/2019

Bill Journey

Originated in the House

Introduced

February 28, 2019

Referred to the House Committee on Energy and Commerce.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House2/28/2019

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors1